8 employees
Navignostics aims to identify the ideal treatment to each cancer patient’s disease.
2022
$7.6M
from 2 investors over 2 rounds
Navignostics AG raised $7.6M on November 9, 2022
Investors: Zürcher Kantonalbank
Navignostics AG raised $1M on August 29, 2022
Investors: University of Zurich (UZH) Tierspital